Literature DB >> 22305797

Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia.

Keun-Tae Kim1, Sung-Il Sohn, Kyung-Hee Cho.   

Abstract

Although essential thrombocythemia (ET) may involve thrombotic complications, including arterial or venous thrombosis, there are no reports of major vascular complications, including both arterial and venous thrombosis, in a patient with ET. We report on a patient with a cerebral infarction affecting the right lateral thalamus and a stenotic lesion of the right posterior cerebral artery. This arterial thrombotic event may be related to ET, which was based on results of a bone marrow biopsy specimen. The patient had experienced previous events of thrombosis, splenic infarction with venous thrombosis, and myocardial infarction. The cause of recurrent ischemic events involving both arterial and venous systems may be sustained elevation of platelet counts. Previous thrombosis is an established risk factor for rethrombosis in patients with ET. Efficient cytoreductive therapy with an antiplatelet agent should be considered for the prevention of recurrent thrombosis. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22305797     DOI: 10.1016/j.jstrokecerebrovasdis.2012.01.005

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  4 in total

1.  The comorbidity of acute ischemic stroke and splenic infarction resulting from essential thrombocythemia.

Authors:  Junliang Yuan; Yanhong Wu; Jianyu Hao; Wenli Hu
Journal:  Neurol Sci       Date:  2018-07-08       Impact factor: 3.307

2.  Splenic Infarct as the Presenting Manifestation of Essential Thrombocythemia.

Authors:  Shalaka Khade; Sudeep Khera; Vaibhav Kumar Varshney; Deepak Kumar Sharma; Raghav Nayar; Abhishek Purohit
Journal:  Ochsner J       Date:  2022

3.  Successive development of ischemic stroke and hemorrhagic stroke in a patient with essential thrombocythemia: a case report.

Authors:  Xuhui Chen; Liming Cao; Hongye Feng; Xuming Huang
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

4.  Essential thrombocythemia with CALR mutation and recurrent stroke: two case reports and literature review.

Authors:  Rong Chen; Xiaodan Shi; Luojun Wang; Xuan Wang; Jingya Wei; Xiaogang Kang; Fang Du; Shan Gao; Fang Yang; Wen Jiang
Journal:  Ther Adv Neurol Disord       Date:  2022-04-26       Impact factor: 6.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.